Lilly sues online vendors, medical spa over copycat weight-loss drugs
By Patrick Wingrove (Reuters) – Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets. The new lawsuits, which name Pivotal Peptides, MangoRx and Genesis Lifestyle Medicine of Nevada, …
Lilly sues online vendors, medical spa over copycat weight-loss drugs Read More »